Статья

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

P. Bastard, E. Orlova, L. Sozaeva, R. Lévy, A. James, M. Schmitt, S. Ochoa, M. Kareva, Y. Rodina, A. Gervais, T. Le Voyer, J. Rosain, Q. Philippot, A. Neehus, E. Shaw, M. Migaud, L. Bizien, O. Ekwall, S. Berg, G. Beccuti, L. Ghizzoni, G. Thiriez, A. Pavot, C. Goujard, M. Frémond, E. Carter, A. Rothenbuhler, A. Linglart, B. Mignot, A. Comte, N. Cheikh, O. Hermine, L. Breivik, E. Husebye, S. Humbert, P. Rohrlich, A. Coaquette, F. Vuoto, K. Faure, N. Mahlaoui, P. Kotnik, T. Battelino, K. Trebušak Podkrajšek, K. Kisand, E. Ferré, T. DiMaggio, L. Rosen, P. Burbelo, M. McIntyre, N. Kann, A. Shcherbina, M. Pavlova, A. Kolodkina, S. Holland, S. Zhang, Y. Crow, L. Notarangelo, H. Su, L. Abel, M. Anderson, E. Jouanguy, B. Neven, A. Puel, J. Casanova, M. Lionakis,
2021

Patients with biallelic loss-of-function variants of AIRE suffer from autoimmune polyendocrine syndrome type-1 (APS-1) and produce a broad range of autoantibodies (auto-Abs), including circulating auto-Abs neutralizing most type I interferons (IFNs). These auto-Abs were recently reported to account for at least 10% of cases of life-threatening COVID-19 pneumonia in the general population. We report 22 APS-1 patients from 21 kindreds in seven countries, aged between 8 and 48 yr and infected with SARS-CoV-2 since February 2020. The 21 patients tested had auto-Abs neutralizing IFN-α subtypes and/or IFN-ω; one had anti-IFN-β and another anti-IFN-ε, but none had anti-IFN-κ. Strikingly, 19 patients (86%) were hospitalized for COVID-19 pneumonia, including 15 (68%) admitted to an intensive care unit, 11 (50%) who required mechanical ventilation, and four (18%) who died. Ambulatory disease in three patients (14%) was possibly accounted for by prior or early specific interventions. Preexisting auto-Abs neutralizing type I IFNs in APS-1 patients confer a very high risk of life-threatening COVID-19 pneumonia at any age.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-07-05

Метаданные

Об авторах
  • P. Bastard
    Hôpital Necker Enfants Malades, Université de Paris, Rockefeller University
  • E. Orlova
    Endocrinology Research Centre
  • L. Sozaeva
    Endocrinology Research Centre
  • R. Lévy
    Hôpital Necker Enfants Malades, Université de Paris, Hôpital Necker Enfants Malades
  • A. James
    National Institute of Allergy and Infectious Diseases (NIAID)
  • M. Schmitt
    National Institute of Allergy and Infectious Diseases (NIAID)
  • S. Ochoa
    National Institute of Allergy and Infectious Diseases (NIAID)
  • M. Kareva
    Endocrinology Research Centre
  • Y. Rodina
    Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
  • A. Gervais
    Hôpital Necker Enfants Malades, Université de Paris
  • T. Le Voyer
    Hôpital Necker Enfants Malades, Université de Paris
  • J. Rosain
    Hôpital Necker Enfants Malades, Université de Paris
  • Q. Philippot
    Hôpital Necker Enfants Malades, Université de Paris
  • A. Neehus
    Hôpital Necker Enfants Malades, Université de Paris
  • E. Shaw
    National Institute of Allergy and Infectious Diseases (NIAID)
  • M. Migaud
    Hôpital Necker Enfants Malades
  • L. Bizien
    Hôpital Necker Enfants Malades
  • O. Ekwall
    Göteborg University, Sahlgrenska Academy, Göteborg University, Sahlgrenska Academy
  • S. Berg
    Göteborg University, Sahlgrenska Academy
  • G. Beccuti
    Università degli Studi di Torino
  • L. Ghizzoni
    Università degli Studi di Torino
  • G. Thiriez
    Hospital Besançon
  • A. Pavot
    Hopital de Bicetre
  • C. Goujard
    Universite Paris-Saclay
  • M. Frémond
    Hôpital Necker Enfants Malades, Université de Paris
  • E. Carter
    Medical Research Council
  • A. Rothenbuhler
    Universite Paris-Saclay
  • A. Linglart
    Universite Paris-Saclay
  • B. Mignot
    Centre Hospitalier Universitaire de Besançon
  • A. Comte
    Centre Hospitalier Universitaire de Besançon
  • N. Cheikh
    Centre Hospitalier Universitaire de Besançon
  • O. Hermine
    Université de Paris, Université de Paris
  • L. Breivik
    Universitetet i Bergen
  • E. Husebye
    Universitetet i Bergen, Helse Bergen Haukeland University Hospital, Karolinska Institutet
  • S. Humbert
    Hospital Besançon
  • P. Rohrlich
    Centre Hospitalier Universitaire de Nice
  • A. Coaquette
    Hospital Besançon
  • F. Vuoto
    University Hospital of Lille
  • K. Faure
    University Hospital of Lille
  • N. Mahlaoui
    Hôpital Necker Enfants Malades, Hôpital Necker Enfants Malades
  • P. Kotnik
    Univerza v Ljubljani Medicinska Fakulteta, University Children's Hospital, Ljubljana
  • T. Battelino
    Univerza v Ljubljani Medicinska Fakulteta, University Children's Hospital, Ljubljana
  • K. Trebušak Podkrajšek
    Univerza v Ljubljani Medicinska Fakulteta, University Children's Hospital, Ljubljana
  • K. Kisand
    Tartu Ülikool
  • E. Ferré
    National Institute of Allergy and Infectious Diseases (NIAID)
  • T. DiMaggio
    National Institute of Allergy and Infectious Diseases (NIAID)
  • L. Rosen
    National Institute of Allergy and Infectious Diseases (NIAID)
  • P. Burbelo
    National Institute of Dental and Craniofacial Research (NIDCR)
  • M. McIntyre
    Royal Alexandra Hospital
  • N. Kann
    Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
  • A. Shcherbina
    Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
  • M. Pavlova
    Sechenov First Moscow State Medical University
  • A. Kolodkina
    Endocrinology Research Centre
  • S. Holland
    National Institute of Allergy and Infectious Diseases (NIAID)
  • S. Zhang
    Hôpital Necker Enfants Malades, Université de Paris, Rockefeller University
  • Y. Crow
    Université de Paris, Medical Research Council
  • L. Notarangelo
    National Institute of Allergy and Infectious Diseases (NIAID)
  • H. Su
    National Institute of Allergy and Infectious Diseases (NIAID)
  • L. Abel
    Hôpital Necker Enfants Malades, Université de Paris, Rockefeller University
  • M. Anderson
    University of California, San Francisco
  • E. Jouanguy
    Hôpital Necker Enfants Malades, Université de Paris, Rockefeller University
  • B. Neven
    Université de Paris, Hôpital Necker Enfants Malades
  • A. Puel
    Hôpital Necker Enfants Malades, Université de Paris, Rockefeller University
  • J. Casanova
    Hôpital Necker Enfants Malades, Université de Paris, Rockefeller University, Howard Hughes Medical Institute
  • M. Lionakis
    National Institute of Allergy and Infectious Diseases (NIAID)
Название журнала
  • The Journal of experimental medicine
Том
  • 218
Выпуск
  • 7
Финансирующая организация
  • National Institute of Allergy and Infectious Diseases
Номер гранта
  • R01 AI088364
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus